Table: Torii Pharmaceutical - 6-MTH parent results
Jul 31 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2019 Jun 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 20.68 30.55 40.80
(-32.3 pct) (+1.5 pct) (-34.8 pct)
Operating 290 mln 2.11 loss 700 mln
(-86.2 pct) (-11.0 pct)
Recurring 402 mln 2.16 loss 400 mln
(-81.4 pct) (-10.4 pct)
Net 26.19 1.55 24.70
(-12.0 pct)
EPS 933.34 yen 55.22 yen 880.07 yen
EPS Diluted 55.21 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)